drugset
drugset / Trial / NCT06122714

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants

NCT06122714 ↗

Phase 1 Completed 95 enrolled AstraZeneca Parexel · collab
RandomizedSequentialDouble-blindTreatment

Summary

This study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ascending doses of AZD4144 administered orally in healthy participants.

Timeline

Start
2023-11-07
Primary completion
2024-12-04
Completion
2024-12-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD4144 Unknown — Oral

Indications

No indication recorded.